An Open-label Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK716155 in Healthy Adult Female Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Albiglutide; Ethinylestradiol/norethisterone
- Indications Pregnancy; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Jan 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 07 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.